相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。CD38 knocKout natural killer cells expressing an affinity optimized CD38 chimeric antigen receptor successfully target acute myeloid leukemia with reduced effector cell fratricide
Mark Gurney et al.
HAEMATOLOGICA (2022)
Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cells
May Daher et al.
BLOOD (2021)
A robust platform for expansion and genome editing of primary human natural killer cells
Rih-Sheng Huang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2021)
CRISPR Screening of CAR T Cells and Cancer Stem Cells Reveals Critical Dependencies for Cell-Based Therapies
Dongrui Wang et al.
CANCER DISCOVERY (2021)
CRISPR-Cas9-Mediated TIM3 Knockout in Human Natural Killer Cells Enhances Growth Inhibitory Effects on Human Glioma Cells
Takayuki Morimoto et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
CRISPR/Cas9 Gene-Editing in Cancer Immunotherapy: Promoting the Present Revolution in Cancer Therapy and Exploring More
Xuejin Ou et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Graft-versus-host disease risk after chimeric antigen receptor T-cell therapy: the diametric opposition of T cells
Khaled Sanber et al.
BRITISH JOURNAL OF HAEMATOLOGY (2021)
Nonviral genome engineering of natural killer cells
Gabrielle M. Robbins et al.
STEM CELL RESEARCH & THERAPY (2021)
Chimeric Antigen Receptor T cell Therapy and the Immunosuppressive Tumor Microenvironment in Pediatric Sarcoma
Rachael L. Terry et al.
CANCERS (2021)
Targeted T cell receptor gene editing provides predictable T cell product function for immunotherapy
Thomas R. Mueller et al.
CELL REPORTS MEDICINE (2021)
A Genetically Engineered Primary Human Natural Killer Cell Platform for Cancer Immunotherapy
Emily J. Pomeroy et al.
MOLECULAR THERAPY (2020)
Polymer-stabilized Cas9 nanoparticles and modified repair templates increase genome editing efficiency
David N. Nguyen et al.
NATURE BIOTECHNOLOGY (2020)
Engineering strategies to overcome the current roadblocks in CAR T cell therapy
Sarwish Rafiq et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
'Off-the-shelf' allogeneic CAR T cells: development and challenges
S. Depil et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
NK cells for cancer immunotherapy
Noriko Shimasaki et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors
Enli Liu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
CRISPR-engineered T cells in patients with refractory cancer
Edward A. Stadtmauer et al.
SCIENCE (2020)
CD38 deletion of human primary NK cells eliminates daratumumab-induced fratricide and boosts their effector activity
Meisam Naeimi Kararoudi et al.
BLOOD (2020)
Use of Cell and Genome Modification Technologies to Generate Improved Off-the-Shelf CAR T and CAR NK Cells
Michael A. Morgan et al.
FRONTIERS IN IMMUNOLOGY (2020)
Drug target validation in primary human natural killer cells using CRISPR RNP
Jai Rautela et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2020)
Natural killer cells in cancer biology and therapy
Song-Yang Wu et al.
MOLECULAR CANCER (2020)
CHANGE-seq reveals genetic and epigenetic effects on CRISPR-Cas9 genome-wide activity
Cicera R. Lazzarotto et al.
NATURE BIOTECHNOLOGY (2020)
Using Gene Editing Approaches to Fine-Tune the Immune System
Kristina Pavlovic et al.
FRONTIERS IN IMMUNOLOGY (2020)
Next-generation cell therapies: the emerging role of CAR-NK cells
Rafet Basar et al.
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2020)
ADAM17-Deficient Pluripotent Stem Cell-Derived Natural Killer Cells Possess Improved Antibody-Dependent Cellular Cytotoxicity and Antitumor Activity
Kenta Yamamoto et al.
BLOOD (2020)
CD33 Targeting Primary CAR-NK Cells Generated By CRISPR Mediated Gene Insertion Show Enhanced Anti-AML Activity
Meisam Naeimi Kararoudi et al.
BLOOD (2020)
Genetic and epigenetic modification of human primary NK cells for enhanced antitumor activity
Meisam Naeimi Kararoudi et al.
SEMINARS IN HEMATOLOGY (2020)
Protocol for Isolation, Stimulation and Functional Profiling of Primary and iPSC-derived Human NK Cells
Janine Melsen et al.
BIO-PROTOCOL (2020)
A guide to cancer immunotherapy: from T cell basic science to clinical practice
Alex D. Waldman et al.
NATURE REVIEWS IMMUNOLOGY (2020)
TGF-β inhibition via CRISPR promotes the long-term efficacy of CAR T cells against solid tumors
Na Tang et al.
JCI INSIGHT (2020)
Role of ADAM17 as a regulatory checkpoint of CD16A in NK cells and as a potential target for cancer immunotherapy
Jianming Wu et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2019)
One-step generation of modular CAR-T cells with AAV-Cpf1
Xiaoyun Dai et al.
NATURE METHODS (2019)
The NKG2A immune checkpoint - a new direction in cancer immunotherapy
Benjamin C. Creelan et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
CRISPR/Cas9-based genome editing in the era of CAR T cell immunotherapy
January Salas-Mckee et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2019)
Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells
Takahiro Kamiya et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Effects of starting cellular material composition on chimeric antigen receptor T-cell expansion and characteristics
Nasha Elavia et al.
TRANSFUSION (2019)
Managing the toxicities of CAR T-cell therapy
Sattva S. Neelapu
HEMATOLOGICAL ONCOLOGY (2019)
Cellular therapy: Adoptive immunotherapy with expanded natural killer cells
Dean A. Lee
IMMUNOLOGICAL REVIEWS (2019)
Genetic reprogramming for NK cell cancer immunotherapy with CRISPR/Cas9
Lukman O. Afolabi et al.
IMMUNOLOGY (2019)
Therapeutic potential of CRISPR/Cas9 gene editing in engineered T-cell therapy
Qianqian Gao et al.
CANCER MEDICINE (2019)
Natural Killer Cells as Allogeneic Effectors in Adoptive Cancer Immunotherapy
Kyle B. Lupo et al.
CANCERS (2019)
Systematic Immunotherapy Target Discovery Using Genome-Scale In Vivo CRISPR Screens in CD8 T Cells
Matthew B. Dong et al.
CELL (2019)
Primary Human NK Cell Gene-Editing Reveals a Critical Role for NKG2A in Cytokine-Induced Memory-like NK Cell Responses
Melissa M. Berrien-Elliott et al.
BLOOD (2019)
Genome-wide CRISPR/Cas9 library screening identified PHGDH as a critical driver for Sorafenib resistance in HCC
Lai Wei et al.
NATURE COMMUNICATIONS (2019)
Synergized regulation of NK cell education by NKG2A and specific Ly49 family members
Xiaoqian Zhang et al.
NATURE COMMUNICATIONS (2019)
Allogeneic CAR T cell therapies for leukemia
Waseem Qasim
AMERICAN JOURNAL OF HEMATOLOGY (2019)
GM-CSF inhibition reduces cytokine release syndrome and neuroinflammation but enhances CAR-T cell function in xenografts
Rosalie M. Sterner et al.
BLOOD (2019)
Recent advances in CAR T-cell toxicity: Mechanisms, manifestations and management
Jennifer N. Brudno et al.
BLOOD REVIEWS (2019)
CRISPR/Cas9-mediated PD-1 disruption enhances human mesothelin-targeted CAR T cell effector functions
Wanghong Hu et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
Cancer immunoediting and resistance to T cell-based immunotherapy
Jake S. O'Donnell et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Targeting REGNASE-1 programs long-lived effector T cells for cancer therapy
Jun Wei et al.
NATURE (2019)
iGUIDE: an improved pipeline for analyzing CRISPR cleavage specificity
Christopher L. Nobles et al.
GENOME BIOLOGY (2019)
Easi-CRISPR for creating knock-in and conditional knockout mouse models using long ssDNA donors
Hiromi Miura et al.
NATURE PROTOCOLS (2018)
Chimeric antigen receptor T-cell therapy - assessment and management of toxicities
Sattva S. Neelapu et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Immune evasion via PD-1/PD-L1 on NK cells and monocyte/macrophages is more prominent in Hodgkin lymphoma than DLBCL
Frank Vari et al.
BLOOD (2018)
Anti-ADAM17 monoclonal antibody MEDI3622 increases IFNγ production by human NK cells in the presence of antibody-bound tumor cells
Hemant K. Mishra et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2018)
CRISPR/Cas9-Mediated Knockout of DGK Improves Antitumor Activities of Human T Cells
In-Young Jung et al.
CANCER RESEARCH (2018)
Optimized RNP transfection for highly efficient CRISPR/Cas9-mediated gene knockout in primary T cells
Akiko Seki et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
CD4 Helper and CD8 Cytotoxic T Cell Differentiation
Ichiro Taniuchi
ANNUAL REVIEW OF IMMUNOLOGY, VOL 36 (2018)
Long Terminal Repeat CRISPR-CAR-Coupled Universal T Cells Mediate Potent Anti-leukemic Effects
Christos Georgiadis et al.
MOLECULAR THERAPY (2018)
Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia
Joseph A. Fraietta et al.
NATURE MEDICINE (2018)
Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia
Jae H. Park et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
S. L. Maude et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Genome-wide and high-density CRISPR-Cas9 screens identify point mutations in PARP1 causing PARP inhibitor resistance
Stephen J. Pettitt et al.
NATURE COMMUNICATIONS (2018)
Generation of Knock-out Primary and Expanded Human NK Cells Using Cas9 Ribonucleoproteins
Meisam Naeimi Kararoudi et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2018)
Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade
Joy Hsu et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Natural Killer Cells: Development, Maturation, and Clinical Utilization
Alex M. Abel et al.
FRONTIERS IN IMMUNOLOGY (2018)
Clustered Regularly interspaced Short Palindromic Repeats/Cas9 Gene editing Technique in Xenotransplantation
Meisam Naeimi Kararoudi et al.
FRONTIERS IN IMMUNOLOGY (2018)
Emerging Cellular Therapies for Cancer
Sonia Guedan et al.
Annual Review of Immunology (2018)
Genome-wide CRISPR Screens in Primary Human T Cells Reveal Key Regulators of Immune Function
Eric Shifrut et al.
CELL (2018)
Allogeneic CAR-T Cells: More than Ease of Access?
Charlotte Graham et al.
CELLS (2018)
Coordination of ENT2-dependent adenosine transport and signaling dampens mucosal inflammation
Carol M. Aherne et al.
JCI INSIGHT (2018)
Disruption of SOCS3 Promotes the Anti-Cancer Efficacy of Primary NK Cells
Meisam Naeimi Kararoudi et al.
BLOOD (2018)
Sequential allogeneic and autologous CAR-T-cell therapy to treat an immune-compromised leukemic patient
Jian-Ping Zhang et al.
BLOOD ADVANCES (2018)
Continuous treatment with IL-15 exhausts human NK cells via a metabolic defect
Martin Felices et al.
JCI INSIGHT (2018)
Inhibition of stromal cell-derived factor-1 alpha/CXCR4 signaling restores the blood-retina barrier in pericyte-deficient mouse retinas
Keisuke Omori et al.
JCI INSIGHT (2018)
CRISPR-Cas9-mediated multiplex gene editing in CAR-T cells
Xiaojuan Liu et al.
CELL RESEARCH (2017)
Driving gene-engineered T cell immunotherapy of cancer
Laura A. Johnson et al.
CELL RESEARCH (2017)
High NKG2A expression contributes to NK cell exhaustion and predicts a poor prognosis of patients with liver cancer
Cheng Sun et al.
ONCOIMMUNOLOGY (2017)
Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization
Silvia Pesce et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Durable Molecular Remissions in Chronic Lymphocytic Leukemia Treated With CD19-Specific Chimeric Antigen Receptor-Modified T Cells After Failure of Ibrutinib
Cameron J. Turtle et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection
Justin Eyquem et al.
NATURE (2017)
Mapping the genomic landscape of CRISPR-Cas9 cleavage
Peter Cameron et al.
NATURE METHODS (2017)
Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening
Julia Joung et al.
NATURE PROTOCOLS (2017)
Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas
Stephen J. Schuster et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
S. S. Neelapu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Increased expression of programmed cell death protein 1 on NK cells inhibits NK-cell-mediated anti-tumor function and indicates poor prognosis in digestive cancers
Y. Liu et al.
ONCOGENE (2017)
CRISPR/Cas9-mediated PD-1 disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells
Levi J. Rupp et al.
SCIENTIFIC REPORTS (2017)
Genome-Editing Technologies in Adoptive T Cell Immunotherapy for Cancer
Nathan Singh et al.
CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2017)
Ectodomain Shedding by ADAM17: Its Role in Neutrophil Recruitment and the Impairment of This Process during Sepsis
Hemant K. Mishra et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2017)
Modeling Human Natural Killer cell Development in the era of innate Lymphoid cells
Steven D. Scoville et al.
FRONTIERS IN IMMUNOLOGY (2017)
Detection of on-target and off-target mutations generated by CRISPR/Cas9 and other sequence-specific nucleases
Julia Zischewski et al.
BIOTECHNOLOGY ADVANCES (2017)
The shedding protease ADAM17: Physiology and pathophysiology
Friederike Zunke et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2017)
Haploidentical Natural Killer Cells Infused before Allogeneic Stem Cell Transplantation for Myeloid Malignancies: A Phase I Trial
Dean A. Lee et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2016)
CD38 Dictates Age-Related NAD Decline and Mitochondrial Dysfunction through an SIRT3-Dependent Mechanism
Juliana Camacho-Pereira et al.
CELL METABOLISM (2016)
CD19 CAR-T cells of defined CD4+: CD8+ composition in adult B cell ALL patients
Cameron J. Turtle et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells
Partow Kebriaei et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Allogeneic T Cells That Express an Anti-CD19 Chimeric Antigen Receptor Induce Remissions of B-Cell Malignancies That Progress After Allogeneic Hematopoietic Stem-Cell Transplantation Without Causing Graft-Versus-Host Disease
Jennifer N. Brudno et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Evaluation of TCR Gene Editing Achieved by TALENs, CRISPR/Cas9, and megaTAL Nucleases
Mark J. Osborn et al.
MOLECULAR THERAPY (2016)
CRISPR knockout screening outperforms shRNA and CRISPRi in identifying essential genes
Bastiaan Evers et al.
NATURE BIOTECHNOLOGY (2016)
CIS is a potent checkpoint in NK cell-mediated tumor immunity
Rebecca B. Delconte et al.
NATURE IMMUNOLOGY (2016)
Immunotherapy of non-Hodgkin's lymphoma with a defined ratio of CD8+ and CD4+ CD19-specific chimeric antigen receptor-modified T cells
Cameron J. Turtle et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Fas ligand and lytic granule differentially control cytotoxic dynamics of natural killer cell against cancer target
Yanting Zhu et al.
ONCOTARGET (2016)
PD-1 mediates functional exhaustion of activated NK cells in patients with Kaposi sarcoma
Asma Beldi-Ferchiou et al.
ONCOTARGET (2016)
A CRISPR Dropout Screen Identifies Genetic Vulnerabilities and Therapeutic Targets in Acute Myeloid Leukemia
Konstantinos Tzelepis et al.
CELL REPORTS (2016)
A Genome-wide CRISPR Screen in Primary Immune Cells to Dissect Regulatory Networks
Oren Parnas et al.
CELL (2015)
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
Daniel W. Lee et al.
LANCET (2015)
NY-ESO-1-specific TCR-engineered T cells mediate sustained antigen-specific antitumor effects in myeloma
Aaron P. Rapoport et al.
NATURE MEDICINE (2015)
Genetic Ablation of CD38 Protects against Western Diet-Induced Exercise Intolerance and Metabolic Inflexibility
Shian-Huey Chiang et al.
PLOS ONE (2015)
Generation of knock-in primary human T cells using Cas9 ribonucleoproteins
Kathrin Schumann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia
David L. Porter et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Churchill: an ultra-fast, deterministic, highly scalable and balanced parallelization strategy for the discovery of human genetic variation in clinical and population-scale genomics
Benjamin J. Kelly et al.
GENOME BIOLOGY (2015)
GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases
Shengdar Q. Tsai et al.
NATURE BIOTECHNOLOGY (2015)
Cas-OFFinder: a fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases
Sangsu Bae et al.
BIOINFORMATICS (2014)
CRISPR-Cas9 Knockin Mice for Genome Editing and Cancer Modeling
Randall J. Platt et al.
CELL (2014)
Low Incidence of Off-Target Mutations in Individual CRISPR-Cas9 and TALEN Targeted Human Stem Cell Clones Detected by Whole-Genome Sequencing
Adrian Veres et al.
CELL STEM CELL (2014)
Whole-Genome Sequencing Analysis Reveals High Specificity of CRISPR/Cas9 and TALEN-Based Genome Editing in Human iPSCs
Cory Smith et al.
CELL STEM CELL (2014)
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
Shannon L. Maude et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
NK Cell Phenotypic Modulation in Lung Cancer Environment
Shi Jin et al.
PLOS ONE (2014)
Targeted and genome-wide sequencing reveal single nucleotide variations impacting specificity of Cas9 in human stem cells
Luhan Yang et al.
NATURE COMMUNICATIONS (2014)
An international effort towards developing standards for best practices in analysis, interpretation and reporting of clinical genome sequencing results in the CLARITY Challenge
Catherine A. Brownstein et al.
GENOME BIOLOGY (2014)
Isolation, Expansion & Function of Cord Blood Natural Killer Cells
Suzanne L. Tomchuck et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
NK cell-based immunotherapy for malignant diseases
Min Cheng et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2013)
Suppression of cytokine signaling: The SOCS perspective
Edmond M. Linossi et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2013)
Blocking the Natural Killer Cell Inhibitory Receptor NKG2A Increases Activity of Human Natural Killer Cells and Clears Hepatitis B Virus Infection in Mice
Fenglei Li et al.
GASTROENTEROLOGY (2013)
Multiplex Genome Engineering Using CRISPR/Cas Systems
Le Cong et al.
SCIENCE (2013)
B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells
James N. Kochenderfer et al.
BLOOD (2012)
Advances in Foamy Virus Vector Technology and Disease Correction Could Speed the Path to Clinical Application
Els Verhoeyen
MOLECULAR THERAPY (2012)
RNA-guided genetic silencing systems in bacteria and archaea
Blake Wiedenheft et al.
NATURE (2012)
Membrane-Bound IL-21 Promotes Sustained Ex Vivo Proliferation of Human Natural Killer Cells
Cecele J. Denman et al.
PLOS ONE (2012)
A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity
Martin Jinek et al.
SCIENCE (2012)
Use of allogeneic NK cells for cancer immunotherapy
Melissa A. Geller et al.
IMMUNOTHERAPY (2011)
A decade's perspective on DNA sequencing technology
Elaine R. Mardis
NATURE (2011)
Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer
Hiu Wing Cheung et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Expansion, Purification, and Functional Assessment of Human Peripheral Blood NK Cells
Srinivas S. Somanchi et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2011)
The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti-PD-1 antibody
Don M. Benson et al.
BLOOD (2010)
Collaboration and competition between DNA double-strand break repair pathways
Elizabeth M. Kass et al.
FEBS LETTERS (2010)
PD-L1 and PD-L2 differ in their molecular mechanisms of interaction with PD-1
Marguerite Ghiotto et al.
INTERNATIONAL IMMUNOLOGY (2010)
Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity
Daniela Pende et al.
BLOOD (2009)
CD38 as a Regulator of Cellular NAD: A Novel Potential Pharmacological Target for Metabolic Conditions
Eduardo Nunes Chini
CURRENT PHARMACEUTICAL DESIGN (2009)
ADAM17 as a Therapeutic Target in Multiple Diseases
Joaquin Arribas et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
IL-15 trans-presentation promotes human NK cell development and differentiation in vivo
Nicholas D. Huntington et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Evolution and function of the ADP ribosyl cyclase/CD38 gene family in physiology and pathology
Fabio Malavasi et al.
PHYSIOLOGICAL REVIEWS (2008)
The enzyme CD38 (a NAD glycohydrolase, EC 3.2.2.5) is necessary for the development of diet-induced obesity
Maria Thereza P. Barbosa et al.
FASEB JOURNAL (2007)
Acquisition of murine NK cell cytotoxicity requires the translation of a pre-existing pool of granzyme B and perforin mRNAs
Todd A. Fehniger et al.
IMMUNITY (2007)
Regulation of SIRT 1 mediated NAD dependent deacetylation: A novel role for the multifunctional enzyme CD38
Pinar Aksoy et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Regulation of intracellular levels of NAD: A novel role for CD38
Pinar Aksoy et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer
JS Miller et al.
BLOOD (2005)
TRAIL identifies immature natural killer cells in newborn mice and adult mouse liver
K Takeda et al.
BLOOD (2005)
Negative regulation of cytokine signaling and immune responses by SOCS proteins
A Yoshimura et al.
ARTHRITIS RESEARCH & THERAPY (2005)
Finishing the euchromatic sequence of the human genome
FS Collins et al.
NATURE (2004)
SOCS-3 inhibits IL-12-induced STAT4 activation by binding through its SH2 domain to the STAT4 docking site in the IL-12 receptor β2 subunit
K Yamamoto et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade
Y Iwai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants
L Ruggeri et al.
SCIENCE (2002)
SOCS proteins: Negative regulators of cytokine signaling
DL Krebs et al.
STEM CELLS (2001)
分享论文
